Literature DB >> 26561569

Triple costimulation via CD80, 4-1BB, and CD83 ligand elicits the long-term growth of Vγ9Vδ2 T cells in low levels of IL-2.

Hyun-Woo Cho1, Su-Yeon Kim1, Dae-Hee Sohn1, Min-Ji Lee1, Mi-Young Park1, Hyun-Jung Sohn1, Hyun-Il Cho2, Tai-Gyu Kim2.   

Abstract

Human γδ T cells play important roles in the regulation of infection and cancer. To understand the roles of costimulatory signals in activation and expansion ex vivo, Vγ9Vδ2 T cells were grown with artificial APCs that express CD83, 4-1BB ligand, and/or CD32, which allowed a loading of αCD3 and αCD28 antibodies. The costimulatory signals through CD80, 4-1BB, and CD83 ligand in low levels of IL-2 triggered an explosive ex vivo proliferation of Vγ9Vδ2 T cells capable of secreting high levels of IL-2, IFN-γ, and TNF-α. Moreover, the triple-costimulatory signals cause augmented cell viabilities for long-term growth of Vγ9Vδ2 T cells, resulting in phenotypic changes to CD27(-)CD45RA(+) effector memory-like cells. Notably, we observed that CD83 ligand signaling is crucial to promote ex vivo expansion, survival, and cytolytic effector functions of Vγ9Vδ2 T cells. In contrast, 4-1BB signaling is moderately important in up-regulating surface molecules on Vγ9Vδ2 T cells. Consequently, γδ T cells stimulated in the presence of triple-costimulatory signals have diverse cytolytic effector molecules, including perforin, granzyme A, granzyme B, and Fas ligand, eliciting potent cytolytic activities against tumor cells. Overall, our results provide insights into the roles of costimulatory signals in manufacturing long-lived and fully functional Vγ9Vδ2 T cells that could be useful against cancers. © Society for Leukocyte Biology.

Entities:  

Keywords:  costimulatory signal; cytotoxicity; expansion; human γδ T cell

Mesh:

Substances:

Year:  2015        PMID: 26561569     DOI: 10.1189/jlb.1HI0814-409RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  4 in total

Review 1.  Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.

Authors:  Fabio Morandi; Mahboubeh Yazdanifar; Claudia Cocco; Alice Bertaina; Irma Airoldi
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

2.  B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.

Authors:  Huimin Lu; Tongguo Shi; Mingyuan Wang; Xiaomi Li; Yanzheng Gu; Xueguang Zhang; Guangbo Zhang; Weichang Chen
Journal:  Oncoimmunology       Date:  2020-04-14       Impact factor: 8.110

Review 3.  γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.

Authors:  Mateus de Souza Barros; Nilberto Dias de Araújo; Fábio Magalhães-Gama; Thaís Lohana Pereira Ribeiro; Fabíola Silva Alves Hanna; Andréa Monteiro Tarragô; Adriana Malheiro; Allyson Guimarães Costa
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

4.  Potentiating Vγ9Vδ2 T cell proliferation and assessing their cytotoxicity towards adherent cancer cells at the single cell level.

Authors:  Chenxiao Liu; Karolina Skorupinska-Tudek; Sven-Göran Eriksson; Ingela Parmryd
Journal:  Biol Open       Date:  2022-02-07       Impact factor: 2.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.